| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04293562 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for… | Acute Myeloid Leukemia | Recruiting |
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | Acute Lymphoblastic Leukemia, Pediatric | Active, Not Recruiting |
| NCT03914625 | A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With… | B Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| Phase 2 | |||
| NCT06918431 | Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults… | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Recruiting |
| NCT06738368 | Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or… | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Recruiting |
| NCT02981628 | Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or… | Recurrent B Acute Lymphoblastic Leukemia | Recruiting |
| NCT06317662 | Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer… | Acute Leukemia of Ambiguous Lineage | Recruiting |
| NCT03164057 | A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia | Acute Myeloid Leukemia | Active, Not Recruiting |
| Phase 1 | |||
| NCT05292664 | Venetoclax Basket Trial for High Risk Hematologic Malignancies | Myelodysplastic Syndromes, de Novo | Recruiting |
| NCT07133997 | Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the… | Recurrent B Acute Lymphoblastic Leukemia | Recruiting |